The majority of HIV infections are initiated at mucosal sites. The oral mucosal tissue has been shown to be a potential route of entry in humans and primates. Whereas HIV RNA, proviral DNA, and infected cells are detected in the oral mucosa and saliva of infected individuals, it appears that the oral mucosa is not permissive for efficient HIV replication and therefore may differ in susceptibility to infection when compared to other mucosal sites. Since there is no definitive information regarding the fate of the HIV virion in mucosal epithelium, there is a pressing need to understand what occurs when the virus is in contact with this tissue, what mechanisms are in play to determine the outcome, and to what degree the mechanisms and outcomes differ between mucosal sites. Workshop 1B tackled 5 important questions to define current knowledge about epithelial cell-derived innate immune agents, commensal and endogenous pathogens, and epithelial cells and cells of the adaptive immune system and how they contribute to dissemination or resistance to HIV infection. Discovering factors that explain the differential susceptibility and resistance to HIV infection in mucosal sites will allow for the identification and development of novel protective strategies.
BáficaAScangaCASchitoMChaussabelDSherA (2004). Influence of coinfecting pathogens on HIV expression: evidence for a role of Toll-like receptors. J Immunol172:7229-7234.
2.
BentwichZKalinkovichAWeismanZ (1995). Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today16:187-191.
3.
BrenGDTrushinSAWhitmanJShepardBBadleyAD (2009). HIV gp120 Induces, NF-κB dependent, HIV replication that requires procaspase 8. PLoS One4:e4875.
4.
BrolidenKHaaseATAhujaSKShearerGMAnderssonJ (2009). Introduction: back to basics. Mucosal immunity and novel HIV vaccine concepts. J Intern Med265:5-17.
5.
ChallacombeSJNaglikJR (2006). The effects of HIV infection on oral mucosal immunity. Adv Dent Res19:29-35.
6.
ChiBHMudendaVLevyJSinkalaMGoldenbergRLStringerJS (2006). Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission. Am J Obstet Gynecol194:174-181.
7.
DaleBAKimballJRKrisanaprakornkitSRobertsFRobinovitchMO’NealR. (2001). Localized antimicrobial peptide expression in human gingiva. J Periodontal Res36:285-294.
8.
DiamondGBeckloffNWeinbergAKisichKO (2009). The roles of antimicrobial peptides in innate host defense. Curr Pharm Des15:2377-2392.
9.
FreemanEEWeissHAGlynnJRCrossPLWhitworthJAHayesRJ (2006). Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS20:73-83.
10.
GeorgeMDVerhoevenDSankaranSGlavanTReayEDandekarS (2009). Heightened cytotoxic responses and impaired biogenesis contribute to early pathogenesis in the oral mucosa of simian immunodeficiency virus-infected rhesus macaques. Clin Vaccine Immunol16:277-281.
11.
GeorgeMDWehkampJKaysRJLeuteneggerCMSabirSGrishinaI. (2008). In vivo gene expression profiling of human intestinal epithelial cells: analysis by laser microdissection of formalin fixed tissues. BMC Genomics9:209.
12.
GiacamanRAAsraniACGebhardKHDietrichEAVacharaksaARossKF. (2008). Porphyromonas gingivalis induces CCR5-dependent transfer of infectious HIV-1 from oral keratinocytes to permissive cells. Retrovirology5:29.
13.
GiacamanRANobbsAHRossKFHerzbergMC (2007). Porphyromonas gingivalis selectively up-regulates the HIV-1 coreceptor CCR5 in oral keratinocytes. J Immunol179:2542-2550.
14.
HanYVenturaCLBlackKPCumminsJEJrHallSDJacksonS (2000). Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland origin. Oral Microbiol Immunol15:82-88.
15.
HaradaHGotoYOhnoTSuzuSOkadaS (2007). Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1. Eur J Immunol37:2148-2155.
16.
HeggelundLMullerFLienEYndestadAUelandTKristiansenKI. (2004). Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. Clin Infect Dis39:264-269.
17.
HladikFHopeTJ (2009). HIV infection of the genital mucosa in women. Curr HIV/AIDS Rep6:20-28.
18.
HladikFSakchalathornPBallweberLLentzGFialkowMEschenbachD. (2007). Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity26:257-270.
19.
HussainLALehnerT (1995). Comparative investigation of Langerhans’ cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology85:475-484.
20.
ImaiKOchiaiKOkamotoT (2009). Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. J Immunol182:3688-3695.
21.
JaspanHBRobinsonJEAmedeeAMVan DykeRBGarryRF (2004). Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies. J Clin Virol31:190-197.
22.
JotwaniRMuthukuruMCutlerCW (2004). Increase in HIV receptors/co-receptors/alpha-defensins in inflamed human gingiva. J Dent Res83:371-377.
23.
KazmiSHNaglikJRSweetSPEvansRWO’SheaSBanatvalaJE. (2006). Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids. Clin Vaccine Immunol13:1111-1118.
24.
KosubDADurudasALehrmanGMilushJMCanoCAJainMK. (2008). Gamma/Delta T cell mRNA levels decrease at mucosal sites and increase at lymphoid sites following an oral SIV infection of macaques. Curr HIV Res6:520-530.
25.
LaneBRMarkovitzDMWoodfordNLRochfordRStrieterRMCoffeyMJ (1999). TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J Immunol163:3653-3661.
26.
LehnerTMitchellEBergmeierLSinghMSpallekRCranageM. (2000). The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection. Eur J Immunol30:2245-2256.
27.
LesterRTYaoXDBallTBMcKinnonLRKaulRWachihiC. (2008). Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS22:685-694.
28.
LewisSHReynolds-KohlerCFoxHENelsonJA (1990). HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet335:565-568.
29.
LiDXuXN (2008). NKT cells in HIV-1 infection. Cell Res18:817-822.
LillyEAYanoJFidelPLJr (2010). Annexin-A1 identified as the oral epithelial cell anti-Candida effector moiety. Mol Oral Microbiol25:293-304.
33.
LinALJohnsonDAStephanKTYehCK (2003). Alteration in salivary function in early HIV infection. J Dent Res82:719-724.
34.
LiuLWangLJiaHPZhaoCHengHHSchutteBC. (1998). Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation. Gene222:237-244.
35.
LiuzziGChirianniAClementiMBagnarelliPValenzaACataldoPT. (1996). Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS10:F51-F56.
36.
MeillerTFHubeBSchildLShirtliffMEScheperMAWinklerR. (2009). A novel immune evasion strategy of Candida albicans: proteolytic cleavage of a salivary antimicrobial peptide. PLoS One4:e5039.
37.
MilushJMKosubDMarthasMSchmidtKScottFWozniakowskiA. (2004). Rapid dissemination of SIV following oral inoculation. AIDS18:2371-2380.
38.
MooreJSRahemtullaFKentLWHallSDIkizlerMRWrightPF. (2003). Oral epithelial cells are susceptible to cell-free and cell-associated HIV-1 infection in vitro. Virology313:343-353.
39.
MoutsopoulosNMNaresSNikitakisNRangelZWenJMunsonP. (2007). Tonsil epithelial factors may influence oropharyngeal human immunodeficiency virus transmission. Am J Pathol171:571-579.
40.
MoyesDLRunglallMMurcianoCShenCNayarDThavarajS. (2010). A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells. Cell Host Microbe8:225-235.
41.
MundyDCSchinaziRFGerberARNahmiasAJRandallHWJr (1987). Human immunodeficiency virus isolated from amniotic fluid. Lancet2:459-460.
42.
MyintMSteinsvollSYuanZNJohneBHelgelandKSchenckK (2002). Highly increased numbers of leukocytes in inflamed gingiva from patients with HIV infection. AIDS16:235-243.
43.
NeutraMRMantisNJKraehenbuhlJP (2001). Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol2:1004-1009.
44.
OngPYOhtakeTBrandtCStricklandIBoguniewiczMGanzT. (2002). Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med347:1151-1160.
45.
Page-ShaferKSweetSKassayeSSsaliC (2006). (C2) Saliva, breast milk, and mucosal fluids in HIV transmission. Adv Dent Res19:152-157.
46.
Quinones-MateuMELedermanMMFengZChakrabortyBWeberJRangelHR. (2003). Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS17:F39-F48.
47.
QureshiMNBarrCEHewlittIBoorsteinRKongFBagasraO. (1997). Detection of HIV in oral mucosal cells. Oral Dis3(suppl 1):73-78.
48.
RebbapragadaAWachihiCPettengellCSunderjiSHuibnerSJaokoW. (2007). Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. AIDS21:589-598.
49.
Rodriguez-IñigoEJiménezEBartoloméJOrtiz-MovillaNBartolomé VillarBJosé ArrietaJ. (2005). Detection of human immunodeficiency virus type 1 RNA by in situ hybridization in oral mucosa epithelial cells from anti-HIV-1 positive patients. J Med Virol77:17-22.
50.
SchackerTZehJHuHShaughnessyMCoreyL (2002). Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis186:1718-1725.
51.
SembaRD (2000). Mastitis and transmission of human immunodeficiency virus through breast milk. Ann N Y Acad Sci918:156-162.
52.
ShacklettBLCritchfieldJWFerreALHayesTL (2009). Mucosal T-cell responses to HIV: responding at the front lines. J Intern Med265:58-66.
53.
SheikhAUPolliottiBMMillerRK (2000). In situ PCR detection of HIV expression in the human placenta. Methods Mol Biol137:75-86.
54.
ShugarsDC (1999). Endogenous mucosal antiviral factors of the oral cavity. J Infect Dis179(suppl 3):431-435.
55.
ShugarsDCWahlSM (1998). The role of the oral environment in HIV-1 transmission. J Am Dent Assoc129:851-858.
56.
SoeiroRRubinsteinARashbaumWKLymanWD (1992). Maternofetal transmission of AIDS: frequency of human immunodeficiency virus type 1 nucleic acid sequences in human fetal DNA. J Infect Dis166:699-703.
57.
SprecherSSoumenkoffGPuissantFDegueldreM (1986). Vertical transmission of HIV in 15-week fetus. Lancet2:288-289.
58.
SteeleCFidelPLJr (2002). Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun70:577-583.
59.
SteeleCLeighJSwobodaRFidelPLJr (2000). Growth inhibition of Candida by human oral epithelial cells. J Infect Dis182:1479-1485.
60.
StringerJSGoldenbergRL (2000). Subclinical chorioamnionitis as a targetable risk factor for vertical transmission of HIV-1. Ann N Y Acad Sci918:77-83.
61.
SunLFinneganCMKish-CataloneTBlumenthalRGarzino-DemoPLa Terra MaggioreGM. (2005). Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol79:14318-14329.
62.
SweetSPCooksonSChallacombeSJ (1995). Candida albicans isolates from HIV-infected and AIDS patients exhibit enhanced adherence to epithelial cells. J Med Microbiol43:452-457.
63.
TahaTEGrayRH (2000). Genital tract infections and perinatal transmission of HIV. Ann N Y Acad Sci918:84-98.
64.
TakedaKAkiraS (2005). Toll-like receptors in innate immunity. Int Immunol17:1-14.
65.
TiemessenCTShalekoffSMeddows-TaylorSSchrammDBPapathanasopoulosMAGrayGE. (2009). Cutting edge: unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1. J Immunol182:5914-5918.
66.
TorresSRGarzino-DemoAMeillerTFMeeksVJabra-RizkMA (2009). Salivary histatin-5 and oral fungal colonisation in HIV+ individuals. Mycoses52:11-15.
67.
VacharaksaAAsraniACGebhardKHFaschingCEGiacamanRAJanoffEN. (2008). Oral keratinocytes support non-replicative infection and transfer of harbored HIV-1 to permissive cells. Retrovirology5:66.
68.
VeazeyRSDeMariaMChalifouxLVShvetzDEPauleyDRKnightHL. (1998). Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science280:427-431.
69.
VeazeyRSGauduinMCMansfieldKGThamICAltmanJDLifsonJD. (2001). Emergence and kinetics of simian immunodeficiency virus-specific CD8(+) T cells in the intestines of macaques during primary infection. J Virol75:10515-10519.
70.
ViscarelloRRCullenMTDeGennaroNJHobbinsJC (1992). Fetal blood sampling in human immunodeficiency virus: seropositive women before elective midtrimester termination of pregnancy. Am J Obstet Gynecol167(4)(pt 1):1075-1079.
71.
VolminkJMahlatiU (2005). HIV: mother to child transmission. Clin Evid14:818-827.
72.
WeindlGNaglikJRKaeslerSBiedermannTHubeBKortingHC. (2007). Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest117:3664-3672.
73.
WillumsenJFFilteauSMCoutsoudisAUebelKENewellMLTomkinsAM (2000). Subclinical mastitis as a risk factor for mother-infant HIV transmission. Adv Exp Med Biol478:211-223.
